ABT

Abbott Laboratories Shs Cert Deposito Arg Repr 0.25 Shs · BCBA:ABT

43,820.00 ARS−160.00 −0.36%

Abbott Laboratories Shs Cert Deposito Arg Repr 0.25 Shs (BCBA:ABT) last traded at 43,820.00 ARS, down 0.36% on the day. Over the past year the stock is down 4.99%. Its 52-week range is 30,380.00 to 51,400.00. It is in the Health Technology sector (Medical Specialties).

Key statistics

Open44,320.00

Day range43,720.00 – 44,400.00

52-week range30,380.00 – 51,400.00

Volume164

Average volume (10 days)2.90 K

Market cap (USD)183.77 B

P/E44.96

EPS (TTM) (USD)0.6384

Dividend yield1.42%

Beta (1 year)−0.1585

Revenue (TTM) (USD)45.56 B

Employees115.00 K

Performance

+2.05%1 week

+11.33%1 month

+4.83%3 months

+35.08%6 months

−7.12%Year to date

−4.99%1 year

Technical reading

Bullish

Daily summary of what 11 oscillators and 15 moving averages show. See every indicator

Latest headlines

Notable analyst calls this week: Broadcom, Moderna and Abbott among top picksSeeking Alpha · 31 Oct 2026
HHS proposes changes to infant formula standardsSeeking Alpha · 29 Oct 2026
Abbott Initiates Pivotal Trial For Cephea™ Device, An Innovative Treatment For Mitral Heart Valve DiseaseReuters · 29 Oct 2026
Abbott Receives FDA Approval For First Device To Treat Leaks After Heart Valve ReplacementReuters · 28 Oct 2026
Abbott downgraded at Argus on guidance cutSeeking Alpha · 27 Oct 2026
Abbott Labs Cut to Hold From Buy by Argus ResearchDow Jones Newswires · 27 Oct 2026
Weekly Recap: Tighter EPS outlook and Exact Sciences in Cancer DiagnosticsTradingView · 26 Oct 2026
Abbott Labs Is Maintained at Overweight by Wells FargoDow Jones Newswires · 23 Oct 2026

Market data from TradingView’s public feed, delayed as the exchange requires. SuperCharting is charting software and gives no investment advice.